Cited by 114Retinal Diseases and TreatmentsRetinal and Macular SurgeryOcular Infections and Treatments

The DOI matches its Crossref record; the references it cites are not checked yet.

Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections

Melo, Gustavo Barreto, Cruz, Natasha Ferreira Santos da, Emerson, Geoffrey Guy, Rezende, Flávio Atanázio, Meyer, Carsten H., Uchiyama, Susumu, Carpenter, John, Shiroma, Hélio Francisco, Farah, Michel Eid, Maia, Maurício, Rodrigues, Eduardo Büchele·2021·Progress in Retinal and Eye Research

Abstract

Intravitreal injections have become the most commonly performed intraocular treatments worldwide. Because intravitreal injections may induce severe adverse events, such as infectious and noninfectious endophthalmitis, cataract, ocular hypertension, vitreous hemorrhage, or retinal detachment, appropriate awareness of the materials and techniques used are essential to reduce these sight-threatening complications. This review provides insights into the needles, syringes, silicone oil coating, sterilization methods, devices to assist intravitreal injections, scleral piercing techniques using needles, syringe handling, anesthesia, and safety issues related to materials and techniques. It is paramount that physicians be aware of every step involved in intravitreal injections and consider the roles and implications of all materials and techniques used. The ability to understand the theoretical and practical circumstances may definitely lead to state-of-the-art treatments delivered to patients. The most important practical recommendations are: choosing syringes with as little silicone oil as possible, or, preferably, none; avoiding agitation of syringes; awareness that most biologics (e.g., antiangiogenic proteins) are susceptible to changes in molecular properties under some conditions, such as agitation and temperature variation; understanding that improper materials and techniques may lead to complications after intravitreal injections, e.g., inflammation; and recognizing that som…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.preteyeres.2020.100862

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists haven’t been fetched yet

References 175 · Cited by 114

Research works printed but not linked: 163

  1. Güler, 2015, Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection, Kor. J. Ophthalmol., 29, 190, 10.3341/kjo.2015.29.3.190 · DOI
  2. Örnek, 2014, Anesthetic effectiveness of topical levobupivacaine 0.75% versus topical proparacaine 0.5% for intravitreal injections, Saudi J. Anaesth., 8, 198, 10.4103/1658-354X.130713 · DOI
  3. Soliman, 2004, Comparative clinical trial of topical anesthetic agents in cataract surgery: lidocaine 2% gel, bupivacaine 0.5% drops, and benoxinate 0.4% drops, J. Cataract Refract. Surg., 30, 10.1016/j.jcrs.2003.12.034 · DOI
  4. Aderman, 2018, Comparing 33-gauge versus 30-gauge needles for intravitreal injections, Ophthalmol. Retina, 2, 1078, 10.1016/j.oret.2018.05.003 · DOI
  5. Agra, 2019, Silicone oil found in syringes commonly used for intravitreal injections, Arq. Bras. Oftalmol., 82, 354, 10.5935/0004-2749.20190080 · DOI
  6. Ahmad, 2019, Under-dosing of drug due to inaccurate syringe markings: vigilance and Quality control-the need of the hour, J. Clin. Anesth., 52, 121, 10.1016/j.jclinane.2018.09.023 · DOI
  7. Aiello, 2004, Evolving guidelines for intravitreous injections, Retina, 24, 10.1097/00006982-200410001-00002 · DOI
  8. Andrade, 2015, Comparison of 3 different anesthetic approaches for intravitreal injections: a prospective randomized trial, Arq. Bras. Oftalmol., 78, 27, 10.5935/0004-2749.20150008 · DOI
  9. Avery, 2014, Intravitreal injection technique and monitoring: update guidelines of an expert panel, Retina, 34, S1, 10.1097/IAE.0000000000000399 · DOI
  10. Avery, 2019, Large silicone droplets after intravitreal bevacizumab (Avastin), Retin. Cases Brief Rep., 13, 130, 10.1097/ICB.0000000000000570 · DOI
  11. Bakri, 2008, Intravitreal silicone oil droplets after intravitreal drug injections, Retina, 28, 996, 10.1097/IAE.0b013e31816c6868 · DOI
  12. Bakri, 2006, Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing, Retina, 26, 519, 10.1097/01.iae.0000225354.92444.7a · DOI
  13. Bakri, 2014, Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials, Ophthalmology, 121, 1102, 10.1016/j.ophtha.2013.11.029 · DOI
  14. Bantseev, 2019, Evaluation of surgical factors affecting vitreous hemorrhage following port delivery system with ranibizumab implant insertion in a minipig model, Retina
  15. Bardocci, 2003, Lidocaine 2% gel versus lidocaine 4% unpreserved drops for topical anesthesia in cataract surgery: a randomized controlled trial, Ophthalmology, 110, 144, 10.1016/S0161-6420(02)01562-2 · DOI
  16. Barnard, 2013, Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity, J. Pharm. Sci., 102, 915, 10.1002/jps.23415 · DOI
  17. Bartfield, 1994, A comparison of proparacaine and tetracaine eye anesthetics, Acad. Emerg. Med., 1, 364, 10.1111/j.1553-2712.1994.tb02646.x · DOI
  18. Basu, 2013, IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers, J. Pharm. Sci., 102, 852, 10.1002/jps.23434 · DOI
  19. Basu, 2014, Albinterferon α2b adsorption to silicone-oil water interfaces: effects of protein conformation, aggregation and subvisible particle formation, J. Pharm. Sci., 103, 427, 10.1002/jps.23821 · DOI
  20. Beaton, 2015, Non-invasive measurement of choroidal volume change and ocular rigidity through automated segmentation of high-speed OCT imaging, Biomed. Optic Express, 6, 1694, 10.1364/BOE.6.001694 · DOI
  21. Benz, 2006, Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide, Ophthalmology, 113, 1174, 10.1016/j.ophtha.2005.10.061 · DOI
  22. Blaha, 2011, Randomized trial of anesthetic methods for intravitreal injections, Retina, 31, 535, 10.1097/IAE.0b013e3181eac724 · DOI
  23. Boden, 2008, Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival, J. Cataract Refract. Surg., 34, 1773, 10.1016/j.jcrs.2008.05.056 · DOI
  24. Bracha, 2018, The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review, Surv. Ophthalmol., 63, 281, 10.1016/j.survophthal.2017.08.008 · DOI
  25. Bucher, 2005, Microbiologic studies of multiple-dose containers of triamcinolone acetonide and lidocaine hydrochloride, Retina, 25, 269, 10.1097/00006982-200504000-00003 · DOI
  26. Bucher, 2005, Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment, Arch. Ophthalmol., 123, 649, 10.1001/archopht.123.5.649 · DOI
  27. Campochiaro, 2019, The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial, Ophthalmology, 126, 1141, 10.1016/j.ophtha.2019.03.036 · DOI
  28. Chan, 2011, Investigating liquid leak from pre-filled syringes upon needle shield removal: effect of air bubble pressure, PDA J. Pharm. Sci. Technol., 65, 363, 10.5731/pdajpst.2011.00759 · DOI
  29. Chandra, 2018, The effectiveness of 2% lidocaine gel compared to 0,5% tetracaine eye drop as topical anesthetic agent for phacoemulsification surgery, Anesthesiol. Pain Med., 28
  30. Chaturvedi, 2019, Real-world trends in intravitreal injections practices among American retina specialists, Ophthalmol. Retina, 3, 656, 10.1016/j.oret.2019.03.023 · DOI
  31. Chavan, 2013, Review on needle free drug delivery systems, Int. J. Pharm. Rev. Res., 2, 30
  32. Chisholm, 2015, In vivo analysis of the potency of silicone oil microdroplets as immunological adjuvants in protein formulations, J. Pharm. Sci., 104, 3681, 10.1002/jps.24573 · DOI · Paper page
  33. Chisholm, 2016, Silicone oil microdroplets can induce antibody responses against recombinant murine growth hormone in mice, J. Pharm. Sci., 105, 1623, 10.1016/j.xphs.2016.02.019 · DOI
  34. Chisholm, 2017, Immunogenicity of structurally perturbed hen egg lysozyme adsorbed to silicone oil microdroplets in wild-type and transgenic mouse models, J. Pharm. Sci., 106, 10.1016/j.xphs.2017.02.008 · DOI · Paper page
  35. Closset, 2017, Physical stability of highly concentrated injectable drug solutions used in intensive care units, Ann. Pharm. Fr., 75, 185, 10.1016/j.pharma.2016.12.004 · DOI
  36. Crul, 2019, Bevacizumab for intravitreal injection: impact of sub-visible particles on the shelf-life of repackaged bevacizumab, J. Ocul. Pharmacol. Therapeut., 35, 372, 10.1089/jop.2019.0042 · DOI
  37. Davis, 2012, Comparison of topical anesthetics for intravitreal injections. A randomized clinical trial, Retina, 32, 701, 10.1097/IAE.0b013e31822f27ca · DOI
  38. De Bardi, 2018, On the needle clogging of staked-in-needle pre-filled syringes: mechanism of liquid entering the needle and solidification process, Eur. J. Pharm. Biopharm., 128, 272, 10.1016/j.ejpb.2018.05.006 · DOI
  39. De Stefano, 2011, Experimental investigation of needles, syringes and techniques for intravitreal injections, Clin. Exp. Ophthalmol., 39, 236, 10.1111/j.1442-9071.2010.02447.x · DOI
  40. Dedania, 2015, Sustained elevation of intraocular pressure after intravitreal anti-VEGF agents: what is the evidence?, Retina, 35, 841, 10.1097/IAE.0000000000000520 · DOI
  41. Deschenes, 2008, International uveitis study group (IUSG): clinical classification of uveitis, Ocul. Immunol. Inflamm., 16, 1, 10.1080/09273940801899822 · DOI
  42. Dias, 2020, Agitation of the syringe and silicone oil, Eye
  43. Dierick, 2016, Ready-to-use prefillable syringes: sterilisation effects on biopharmaceuticals, ONdrugDelivery Magazine, 71, 50
  44. Dill, 2019, Mechanical shock during shipping of medications: the roles of packaging and transportation vendors, J. Pharm. Sci., 30721
  45. Döge, 1985, [The storage capability of pre-filled disposable plastic syringes], Pharmazie, 40
  46. Doshi, 2011, Intravitreal injection technique, Semin. Ophthalmol., 26, 104, 10.3109/08820538.2010.541318 · DOI
  47. Doshi, 2011, Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis, Ophthalmic Surg. Laser. Imag., 42, 346, 10.3928/15428877-20110210-02 · DOI
  48. Eadie, 2017, Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery, JAMA. Ophthalmol., 135, 363, 10.1001/jamaophthalmol.2017.0059 · DOI
  49. Eaton, 2013, Assessment of novel guarded needle to increase patient comfort and decrease injection time during intravitreal injection, Ophthalmic Surg. Lasers Imaging Retina, 44, 561, 10.3928/23258160-20131105-06 · DOI
  50. Egekvist, 1999, Pain and mechanical injury of human skin following needle insertions, Eur. J. Pain, 3, 41, 10.1016/S1090-3801(99)90187-8 · DOI
  51. Emerson, 2017, Silicone oil droplets are more common in fluid from BD insulin syringes as compared to other syringes, J. VitreoRet. Dis., 1401-406
  52. Freund, 2006, Silicone oil droplets following intravitreal injections, Retina, 26, 701, 10.1097/01.iae.0000223177.08438.2b · DOI
  53. Friedrich, 1997, Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume, Curr. Eye Res., 16, 663, 10.1076/ceyr.16.7.663.5061 · DOI
  54. Funatsu, 2019, Impact of ethylene oxide sterilization of polymer-based prefilled syringes on chemical degradation of a model therapeutic protein during storage, J. Pharm. Sci., 108, 770, 10.1016/j.xphs.2018.09.029 · DOI
  55. Funke, 2015, Analysis of thin baked-on silicone layers by FTIR and 3D-laser scanning microscopy, Eur. J. Pharm. Biopharm., 96, 304, 10.1016/j.ejpb.2015.08.009 · DOI
  56. Gerhardt, 2013, Ionic strength affects tertiary structure and aggregation propensity of a monoclonal antibody adsorbed to silicone oil-water interfaces, J. Pharm. Sci., 102, 429, 10.1002/jps.23408 · DOI
  57. Gerhardt, 2015, Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes, J. Pharm. Sci., 104, 1601, 10.1002/jps.24387 · DOI
  58. Gerhardt, 2015, Surfactant effects on particle generation in antibody formulations in pre-filled syringes, J. Pharm. Sci., 104, 4056, 10.1002/jps.24654 · DOI
  59. Goldberg, 2012, An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab, Am. J. Ophthalmol., 153, 204, 10.1016/j.ajo.2011.11.035 · DOI
  60. Goldberg, 2014, Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes, Am. J. Ophthalmol., 158, 733, 10.1016/j.ajo.2014.06.019 · DOI · Paper page
  61. Gote, 2019, Ocular drug delivery: present innovations and future challenges, J. Pharmacol. Exp. Therapeut., 370, 602, 10.1124/jpet.119.256933 · DOI · Paper page
  62. Green-Simms, 2011, Survey of intravitreal injection techniques among retinal specialists in the United States, Am. J. Ophthalmol., 151, 329, 10.1016/j.ajo.2010.08.039 · DOI
  63. Greenberg, 2019, Aflibercept-related sterile intraocular inflammation outcomes, Ophthalmol. Retina, 3, 753, 10.1016/j.oret.2019.04.006 · DOI · Paper page
  64. Gregori, 2012, Randomized clinical trial of two anesthetic techniques for intravitreal injections: 4% liquid lidocaine on cotton swabs versus 3.5% lidocaine gel, Expert Opin. Drug Deliv., 9, 735
  65. Haas, 2016, Needle size in intravitreal injections- pain evaluation of a randomized clinical trial, Acta Ophthalmol., 94, 198, 10.1111/aos.12901 · DOI
  66. Hahn, 2015, Postmarketing analysis of aflibercept-related sterile intraocular inflammation, JAMA. Ophthalmol., 133, 421, 10.1001/jamaophthalmol.2014.5650 · DOI · Paper page
  67. Han, 2012, Models of the cutting-edge geometry of medical needles with applications to needle design, Int. J. Mech. Sci., 65, 157, 10.1016/j.ijmecsci.2012.09.014 · DOI
  68. Herrero-Vanrell, 2014, The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies, Prog. Retin. Eye Res., 42, 27, 10.1016/j.preteyeres.2014.04.002 · DOI
  69. Hicks, 1972, Stability of sodium bicarbonate injection stored in polypropylene syringes, Am. J. Hosp. Pharm., 29, 210
  70. Hubschman, 2010, Experimental model of intravitreal injection techniques, Retina, 30, 167, 10.1097/IAE.0b013e3181b094cf · DOI
  71. Jenke, 2014, Extractables and leachables considerations for prefilled syringes, Expet Opin. Drug Deliv., 11, 1591, 10.1517/17425247.2014.928281 · DOI
  72. Jones, 2005, Silicone oil induced aggregation of proteins, J. Pharm. Sci., 94, 918, 10.1002/jps.20321 · DOI
  73. Jones, 2018, Considerations for the use of polysorbates in biopharmaceuticals, Pharm. Res. (N. Y.), 35, 148, 10.1007/s11095-018-2430-5 · DOI
  74. Kahook, 2010, High-molecular-weight aggregates in repackage bevacizumab, Retina, 30, 887, 10.1097/IAE.0b013e3181d50cea · DOI
  75. Kelly, 1948, A note on intravitreous penicillin, Br. J. Ophthalmol., 32, 153, 10.1136/bjo.32.3.153 · DOI
  76. Kent, 2013, Striving to improve intravitreal injections, Rev. Ophthalmol., 20, 14
  77. Khalili, 2015, Storage stability of bevacizumab in polycarbonate and polypropylene syringes, Eye, 29, 820, 10.1038/eye.2015.28 · DOI
  78. Khurana, 2017, Presumed silicone oil droplets in the vitreous cavity after intravitreal bevacizumab injection with insulin syringes, JAMA. Ophthalmol., 135, 800, 10.1001/jamaophthalmol.2017.1815 · DOI
  79. Kiminami, 2017, Impact of sterilization method on protein aggregation and particle formation in polymer-based syringes, J. Pharm. Sci., 106, 1001, 10.1016/j.xphs.2016.12.007 · DOI
  80. Knecht, 2009, Tunneled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort, Retina, 29, 1175, 10.1097/IAE.0b013e3181aade74 · DOI
  81. Kozak, 2006, Prefilled syringe needles versus standard removable needles for intravitreous injection, Retina, 26, 679, 10.1097/01.iae.0000236481.40056.25 · DOI
  82. Krayukhina, 2015, Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins, J. Pharm. Sci., 104, 527, 10.1002/jps.24184 · DOI · Paper page
  83. Kumar, 2008, Assessment of comfort during intra‐ vitreal injections and comparison of anaesthetic drops and subconjunctival anaesthesia, Asian J. Ophthalmol., 10, 185
  84. Lad, 2006, Minimizing the risk of endophthalmitis following intravitreal injections, Compr. Ophthalmol. Update, 7, 277
  85. Lawerson, 1998, Comparison of the tolerability and efficacy of unit-dose, preservative-free topical ocular anesthetics, Ophthalmic Physiol. Optic., 18, 393, 10.1046/j.1475-1313.1998.00381.x · DOI
  86. Lee, 2019, Gene therapy for visual loss: opportunities and concerns, Prog. Retin. Eye Res., 68, 31, 10.1016/j.preteyeres.2018.08.003 · DOI
  87. Lemes, 2019, Effect of injection solutions in the dispersion of syringe lubricant (silicone oil), J. Am. Acad. Dermatol.
  88. Leopold, 1945, Intravitreal penetration of penicillin and penicillin therapy of infections of the vitreous, Arch. Ophthalmol., 33, 211, 10.1001/archopht.1945.00890150055008 · DOI
  89. Lesk, 2019, Intraocular pressure spikes following therapeutic intravitreal injections are correlated with ocular rigidity, Invest. Ophthalmol. Vis. Sci., 60, 2249
  90. Liu, 2011, Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling, Invest. Ophthalmol. Vis. Sci., 22, 1023, 10.1167/iovs.10-6431 · DOI · Paper page
  91. Lode, 2019, A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes, Sci. Rep., 9, 18021, 10.1038/s41598-019-54226-7 · DOI · Paper page
  92. Lopez-Guajardo, 2008, Reduction of pegaptanib loss during intravitreal delivery using an oblique injection technique, Eye, 22, 430, 10.1038/sj.eye.6703054 · DOI
  93. Lorenz, 2010, Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle, Graefes Arch. Clin. Exp. Ophthalmol., 248, 1573, 10.1007/s00417-010-1490-y · DOI
  94. Ludwig, 2011, Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations, Anal. Biochem., 410, 191, 10.1016/j.ab.2010.12.008 · DOI
  95. Maruno, 2018, Sweeping of adsorbed therapeutic protein on prefillable syringes promotes micro aggregate generation, J. Pharm. Sci., 107, 1521, 10.1016/j.xphs.2018.01.021 · DOI
  96. Mehta, 2015, Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation, J. Pharm. Sci., 104, 1282, 10.1002/jps.24358 · DOI
  97. Mehta, 2016, Colloidal instability fosters agglomeration of subvisible particles created by rupture of gels of a monoclonal antibody formed at silicone oil-water interfaces, J. Pharm. Sci., 105, 2338, 10.1016/j.xphs.2016.06.010 · DOI
  98. Melo, 2019, Release of silicone oil from syringes, Int. J. Retina Vitreous, 5, 1, 10.1186/s40942-018-0153-8 · DOI · Paper page
  99. Melo, 2019, Prevalence of silicone oil droplets in eyes treated with intravitreal injection, Int. J. Retina Vitreous, 5, 34, 10.1186/s40942-019-0184-9 · DOI
  100. Melo, 2019, Release of silicone oil and the off-label use of syringes in ophthalmology, Br. J. Ophthalmol.
  101. Melo, 2019, Needles as a source of silicone oil during intravitreal injection, Eye, 33, 1025, 10.1038/s41433-019-0365-7 · DOI
  102. Melo, 2019, Inflammatory reaction after aflibercept intravitreal injections associated with silicone oil droplets released from syringes: a case-control study, Ophthalmic Surg. Lasers Imaging Retina, 50, 288, 10.3928/23258160-20190503-05 · DOI · Paper page
  103. Melo, 2020, Survey among retina specialists in Brazil about inflammatory reactions after intravitreal antiangiogenic therapy, Arq. Bras. Oftalmol., 83, 10.5935/0004-2749.20200031 · DOI
  104. Merani, 2015, Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review, Int. J. Retina Vitreous, 21, 1
  105. Nakamura, 2015, A strategy for the prevention of protein oxidation by drug product in polymer-based syringes, PDA J. Pharm. Sci. Technol., 69, 88, 10.5731/pdajpst.2015.01009 · DOI
  106. Nakamura, 2015, Assessment of the effects of sterilization methods on protein drug stability by elucidating decomposition mechanism and material analysis, Int. J. Pharm., 484, 51, 10.1016/j.ijpharm.2015.02.020 · DOI
  107. Özkaya, 2013, Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure, J. Ocul. Pharmacol. Therapeut., 29, 325, 10.1089/jop.2012.0144 · DOI
  108. Pacheco, 2013, Effects of microparticle size and Fc density on macrophage phagocytosis, PloS One, 8, 10.1371/journal.pone.0060989 · DOI
  109. Palmer, 2013, Quality of bevacizumab compounded for intravitreal administration, Eye, 27, 1090, 10.1038/eye.2013.139 · DOI
  110. Pang, 2015, Association between needle size, postinjection reflux and intraocular pressure spikes after intravitreal injections, Retina, 35, 1401, 10.1097/IAE.0000000000000476 · DOI
  111. Patel, 2013, Toxicity of topical ophthalmic anesthetics, Expet Opin. Drug Metabol. Toxicol., 9, 983, 10.1517/17425255.2013.794219 · DOI
  112. Peláez, 2018, Container closure integrity testing of prefilled syringes, J. Pharm. Sci., 107, 2091, 10.1016/j.xphs.2018.03.025 · DOI
  113. Perera, 2019, Probing the interfacial interactions of monoclonal and bispecific antibodies at the silicone oil-aqueous solution interface by using sum frequency generation vibrational spectroscopy, Langmuir, 35, 14339, 10.1021/acs.langmuir.9b02768 · DOI
  114. Peterson, 2019, Long-term physical stability, sterility, and anti-VEGF bioactivity of repackaged bevacizumab in 2-mL glass vials, Retina, 39, 1802, 10.1097/IAE.0000000000002212 · DOI
  115. Pulido, 2007, The use of 31-gauge needles and syringes for intraocular injections, Eye, 21, 829, 10.1038/sj.eye.6702514 · DOI
  116. Pulido, 2007, Scleral penetration force requirements for commonly used intravitreal needles, Eye, 21, 1210, 10.1038/sj.eye.6702577 · DOI
  117. Qadry, 1999, Model development for O2 and N2 permeation rates through CZ-resin vials, Int. J. Pharm., 188, 173, 10.1016/S0378-5173(99)00220-3 · DOI
  118. Randolph, 2015, Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation, J. Pharm. Sci., 104, 602, 10.1002/jps.24259 · DOI
  119. Ratnarajan, 2013, Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique, Br. J. Ophthalmol., 97, 395, 10.1136/bjophthalmol-2012-302155 · DOI
  120. Rifkin, 2012, Factors affecting patients' pain intensity during in office intravitreal injection procedure, Retina, 32, 696, 10.1097/IAE.0b013e3182252ad3 · DOI
  121. Rodrigues, 2007, Tunneled scleral incision to prevent vitreal reflux after intravitreal injection, Am. J. Ophthalmol., 143, 1035, 10.1016/j.ajo.2007.01.035 · DOI
  122. Rodrigues, 2009, Therapeutic monoclonal antibodies in ophthalmology, Prog. Retin. Eye Res., 28, 117, 10.1016/j.preteyeres.2008.11.005 · DOI
  123. Rodrigues, 2011, Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection, J. Ocul. Pharmacol. Therapeut., 27, 197, 10.1089/jop.2010.0082 · DOI
  124. Sacha, 2010, Practical fundamentals of glass, rubber, and plastic sterile packaging systems, Pharmaceut. Dev. Technol., 15, 6, 10.3109/10837450903511178 · DOI
  125. Sasajima, 2018, A randomized trial of a short 34-gauge needle for intravitreal injections, Ophthalmology, 125, 947, 10.1016/j.ophtha.2018.01.038 · DOI
  126. Sayah, 2020, Non-invasive in vivo measurement of ocular rigidity: clinical validation, repeatability and method improvement, Exp. Eye Res., 190, 107831, 10.1016/j.exer.2019.107831 · DOI
  127. Schargus, 2018, Contamination of anti-VEGF drugs for intravitreal injection: how do repackaging and newly developed syringes affect the amount of silicone oil droplets and protein aggregates?, Retina, 38, 2088, 10.1097/IAE.0000000000001809 · DOI
  128. Schmidt-Erfurth, 2007, Management of neovascular age-related macular degeneration, Prog. Retin. Eye Res., 26, 437, 10.1016/j.preteyeres.2007.03.002 · DOI
  129. Scott, 2009, SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design, Am. J. Ophthalmol., 148, 725, 10.1016/j.ajo.2009.06.004 · DOI
  130. Scurlock, 1978, The clinical character of local anesthetics: a function of frequency-dependent conduction block, Acta Anesth. Scand., 22, 601, 10.1111/j.1399-6576.1978.tb01343.x · DOI
  131. Shah, 2010, A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia, Local Reg. Anesth., 57
  132. Shiroma, 2014, Safety and efficacy of various concentrations of topical lidocaine gel for intravitreal injection, Expet Opin. Drug Saf., 13, 1299, 10.1517/14740338.2014.947261 · DOI
  133. Shiroma, 2017, Patient pain during intravitreal injections under topical anesthesia: a systematic review, Int. J. Retina Vitreous, 3, 23, 10.1186/s40942-017-0076-9 · DOI
  134. Shiroma, 2019, RE: stem MS, et al: predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength, Ophthalmol Retina, 3, 3
  135. Sitzman, 1996, The effects of needle type, gauge, and tip bend on spinal needle deflection, Anesth. Analg., 82, 297
  136. Small, 2019, Fungal endophthalmitis after intravitreal injections of triamcinolone contaminated by a compounding pharmacy: five-year follow-up of 23 patients, Ophthalmol. Retina, 3, 133, 10.1016/j.oret.2018.09.009 · DOI
  137. Speaker, 1991, A study of the interaction of selected drugs and plastic syringes, J. Parenter. Sci. Technol., 45, 212
  138. Stem, 2019, Predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength, Ophthalmol. Retina, 3, 3, 10.1016/j.oret.2018.09.013 · DOI
  139. Symington, 2006, A review of the use of propofol for procedural sedation in the emergency department, Emerg. Med. J., 23, 89, 10.1136/emj.2005.023713 · DOI
  140. Ta, 2004, Minimizing the risk of endophthalmitis following intravitreous injections, Retina, 24, 699, 10.1097/00006982-200410000-00003 · DOI
  141. Tah, 2015, Anti-VEGF therapy and the retina: an update, J. Ophthalmol., 2015, 627674, 10.1155/2015/627674 · DOI
  142. Teska, 2016, Aggregation and particle formation of therapeutic proteins in contact with a novel fluoropolymer surface versus siliconized surfaces: effects of agitation in vials and in prefilled syringes, J. Pharm. Sci., 105, 2053, 10.1016/j.xphs.2016.04.015 · DOI
  143. Thirumangalathu, 2009, Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution, J. Pharm. Sci., 98, 3167, 10.1002/jps.21719 · DOI
  144. Thompson, 2011, Advantages and limitations of small gauge vitrectomy, Surv. Ophthalmol., 56, 162, 10.1016/j.survophthal.2010.08.003 · DOI
  145. Torisu, 2017, Friability testing as a new stress-stability assay for biopharmaceuticals, J. Pharm. Sci., 106, 2966, 10.1016/j.xphs.2017.05.035 · DOI · Paper page
  146. Tufan, 2013, Bacterial contamination of needles used for intravitreal injections: comparison between 27-gauge and 30-gauge needles, Ocul. Immunol. Inflamm., 21, 366, 10.3109/09273948.2013.801988 · DOI
  147. Uchino, 2015, Reconstitution of L-asparaginase in siliconized syringes with shaking and headspace air induces protein aggregation, Chem. Pharm. Bull., 63, 770, 10.1248/cpb.c15-00242 · DOI
  148. Ueda, 2019, Effects of product handling parameters on particle levels in a commercial Factor VIII product: impacts and mitigation, J. Pharm. Sci., 108, 775, 10.1016/j.xphs.2018.08.022 · DOI
  149. Ullrich, 2016, Assistive device for efficient intravitreal injections, Ophthalmic Surg. Lasers Imaging Retina, 47, 752, 10.3928/23258160-20160808-09 · DOI
  150. Van Asten, 2015, Are intravitreal injections with ultrathin 33-g needles less painful than the commonly used 30-G needles?, Retina, 35, 1778, 10.1097/IAE.0000000000000550 · DOI
  151. VanderBeek, 2019, The argument for sterile loading of all intravitreal injections and the benefit of replicated results, JAMA. Ophthalmol., 137, 343, 10.1001/jamaophthalmol.2018.7089 · DOI
  152. Waqar, 2019, Comment on: optimisation of intravitreal injection technique using a Barraquer speculum with solid flat blade and finger stabilisation, Eye, 33, 512, 10.1038/s41433-018-0248-3 · DOI
  153. Waxman, 2017, A comparison of protein stability in prefillable syringes made of glass and plastic, PDA J. Pharm. Sci. Technol., 71, 462, 10.5731/pdajpst.2016.007146 · DOI
  154. Wells, 2016, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial, Ophthalmology, 123, 1351, 10.1016/j.ophtha.2016.02.022 · DOI
  155. Wen, 2017, Intravitreal anti-VEGF injections reduce aqueous outflow facility in patients with neovascular age-related macular degeneration, Invest. Ophthalmol. Vis. Sci., 58, 1893, 10.1167/iovs.16-20786 · DOI
  156. Werner, 2019, Silicone oil-free polymer syringes for the storage of therapeutic proteins, J. Pharm. Sci., 108, 1148, 10.1016/j.xphs.2018.10.049 · DOI
  157. Williams, 2014, IVT injections: health policy implications, Rev. Ophthalmol., 21, 62
  158. Wood, 2019, Nanovitreoretinal subretinal gateway device to displace submacular hemorrhage: access to the subretinal space without vitrectomy, Retina
  159. Xu, 2012, Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade, Invest. Ophthalmol. Vis. Sci., 53, 5221, 10.1167/iovs.12-9702 · DOI
  160. Yahalomi, 2019, Reduction of postintravitreal injection pain using ice: an open-label interventional randomized controlled trial, Retina
  161. Yannuzzi, 2015, Evaluation of compounded bevacizumab prepared for intravitreal injection, JAMA. Ophthalmol., 133, 32, 10.1001/jamaophthalmol.2014.3591 · DOI
  162. Yau, 2011, Intravitreal injection anesthesia - comparison of different topical agents: a prospective randomized controlled trial, Am. J. Ophthalmol., 151, 333, 10.1016/j.ajo.2010.08.031 · DOI
  163. Yoshino, 2014, Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system, J. Pharm. Sci., 103, 1520, 10.1002/jps.23945 · DOI

Metadata

Authors
Melo, G. B., Cruz, N. F. S. D., Emerson, G. G., Rezende, F. A., Meyer, C. H., Uchiyama, S., Carpenter, J., Shiroma, H. F., Farah, M. E., Maia, M., & Rodrigues, E. B.
Affiliations
  • Universidade Federal de São Paulo (BR)
  • The Retina Center (US)
  • Hôpital Maisonneuve-Rosemont (CA)
  • Philipps University of Marburg (DE)
  • The University of Osaka (JP)
  • University of Colorado Denver (US)
  • Saint Louis University Hospital (US)
Corresponding author
Melo, Gustavo Barreto
Venue
Progress in Retinal and Eye Research
Publisher
Elsevier BV
Published
2021-01
Volume
80
Pages
100862
ISSN
1350-9462 (ISSN-L)
OpenAlex
W3016654382
Cited by
114
References
175
Citations by year
2026: 18 · 2025: 27 · 2024: 15 · 2023: 18 · 2022: 14 · 2021: 18
FWCI
2.29
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Retinal and Eye Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Japan Agency for Medical Research and Development
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Pan-American Association of Ophthalmology
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
intravitreal injection, syringes, needles, silicone oil coating, sterilization, endophthalmitis, ocular hypertension, vitreous hemorrhage, retinal detachment, injection complications, injection safety
MeSH terms
Animals, Disposable Equipment, Humans, Needles, Silicone Oils, Syringes, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review